volume 49 issue 12 pages 3496-3500

Inhibition of Carbonic Anhydrase-II by Sulfamate and Sulfamide Groups:  An Investigation Involving Direct Thermodynamic Binding Measurements

Alexandra L Klinger 1
David F. McComsey 1
Virginia Smith Swintosky 1
Richard P. Shank 1
Bruce E Maryanoff 1
1
 
Research & Early Development, Johnson & Johnson Pharmaceutical Research & Development, Spring House, Pennsylvania 19477-0776
Publication typeJournal Article
Publication date2006-05-19
scimago Q1
wos Q1
SJR1.801
CiteScore11.5
Impact factor6.8
ISSN00222623, 15204804
PubMed ID:  16759092
Drug Discovery
Molecular Medicine
Abstract
This paper examines the relative effectiveness of bioisosteric sulfamate and sulfamide derivatives for inhibition of human carbonic anhydrase-II (CA-II) by using a direct binding assay based on the ThermoFluor method (Matulis et al. Biochemistry 2005, 44, 5258). Compounds 1-10, which represent five cognate sulfamate/sulfamide pairs, were studied by ThermoFluor to obtain binding affinities (K(a) values). The corresponding dissociation constants, K(d), provide an independent measure of CA-II activity relative to commonly used K(i) values from enzyme kinetics studies. There was a sizable difference in potency between the sulfamates and sulfamides, with the sulfamides being much less potent, by factors ranging from 25 (7/8) to 1,200 (3/4). These results are consistent with our recent report that sulfamides tend to be much weaker inhibitors of CA-II than their corresponding sulfamates (Maryanoff et al. J. Med. Chem. 2005, 48, 1941). Additionally, for arylsulfamides 10-12 the K(d) values determined by ThermoFluor and the K(i) values determined from enzyme kinetics are consistent. It appears that the sulfamide group is less suitable than the sulfamate group for obtaining potent inhibition of CA-II.
Found 
Found 

Top-30

Journals

1
2
3
4
5
6
Journal of Medicinal Chemistry
6 publications, 18.75%
Journal of Enzyme Inhibition and Medicinal Chemistry
3 publications, 9.38%
PeerJ
1 publication, 3.13%
American Journal of Therapeutics
1 publication, 3.13%
Mendeleev Communications
1 publication, 3.13%
Biochemical and Biophysical Research Communications
1 publication, 3.13%
PLoS ONE
1 publication, 3.13%
Bioorganic and Medicinal Chemistry Letters
1 publication, 3.13%
Biophysical Journal
1 publication, 3.13%
Tetrahedron Asymmetry
1 publication, 3.13%
Methods
1 publication, 3.13%
Bioorganic and Medicinal Chemistry
1 publication, 3.13%
Chemical Biology and Drug Design
1 publication, 3.13%
CNS Neuroscience and Therapeutics
1 publication, 3.13%
Journal not defined
1 publication, 3.13%
Medicinal Research Reviews
1 publication, 3.13%
British Journal of Clinical Pharmacology
1 publication, 3.13%
Journal of Molecular Recognition
1 publication, 3.13%
Archiv der Pharmazie
1 publication, 3.13%
Chemical Reviews
1 publication, 3.13%
Methods in Enzymology
1 publication, 3.13%
Antimicrobial Agents and Chemotherapy
1 publication, 3.13%
BioMed Research International
1 publication, 3.13%
International Journal of Medicinal Chemistry
1 publication, 3.13%
TrAC - Trends in Analytical Chemistry
1 publication, 3.13%
1
2
3
4
5
6

Publishers

1
2
3
4
5
6
7
8
Elsevier
8 publications, 25%
Wiley
7 publications, 21.88%
American Chemical Society (ACS)
7 publications, 21.88%
Taylor & Francis
3 publications, 9.38%
Hindawi Limited
2 publications, 6.25%
PeerJ
1 publication, 3.13%
Ovid Technologies (Wolters Kluwer Health)
1 publication, 3.13%
Public Library of Science (PLoS)
1 publication, 3.13%
Biophysical Society
1 publication, 3.13%
American Society for Microbiology
1 publication, 3.13%
1
2
3
4
5
6
7
8
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
32
Share
Cite this
GOST |
Cite this
GOST Copy
Klinger A. L. et al. Inhibition of Carbonic Anhydrase-II by Sulfamate and Sulfamide Groups: An Investigation Involving Direct Thermodynamic Binding Measurements // Journal of Medicinal Chemistry. 2006. Vol. 49. No. 12. pp. 3496-3500.
GOST all authors (up to 50) Copy
Klinger A. L., McComsey D. F., Smith Swintosky V., Shank R. P., Maryanoff B. E. Inhibition of Carbonic Anhydrase-II by Sulfamate and Sulfamide Groups: An Investigation Involving Direct Thermodynamic Binding Measurements // Journal of Medicinal Chemistry. 2006. Vol. 49. No. 12. pp. 3496-3500.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1021/jm058279n
UR - https://doi.org/10.1021/jm058279n
TI - Inhibition of Carbonic Anhydrase-II by Sulfamate and Sulfamide Groups: An Investigation Involving Direct Thermodynamic Binding Measurements
T2 - Journal of Medicinal Chemistry
AU - Klinger, Alexandra L
AU - McComsey, David F.
AU - Smith Swintosky, Virginia
AU - Shank, Richard P.
AU - Maryanoff, Bruce E
PY - 2006
DA - 2006/05/19
PB - American Chemical Society (ACS)
SP - 3496-3500
IS - 12
VL - 49
PMID - 16759092
SN - 0022-2623
SN - 1520-4804
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2006_Klinger,
author = {Alexandra L Klinger and David F. McComsey and Virginia Smith Swintosky and Richard P. Shank and Bruce E Maryanoff},
title = {Inhibition of Carbonic Anhydrase-II by Sulfamate and Sulfamide Groups: An Investigation Involving Direct Thermodynamic Binding Measurements},
journal = {Journal of Medicinal Chemistry},
year = {2006},
volume = {49},
publisher = {American Chemical Society (ACS)},
month = {may},
url = {https://doi.org/10.1021/jm058279n},
number = {12},
pages = {3496--3500},
doi = {10.1021/jm058279n}
}
MLA
Cite this
MLA Copy
Klinger, Alexandra L., et al. “Inhibition of Carbonic Anhydrase-II by Sulfamate and Sulfamide Groups: An Investigation Involving Direct Thermodynamic Binding Measurements.” Journal of Medicinal Chemistry, vol. 49, no. 12, May. 2006, pp. 3496-3500. https://doi.org/10.1021/jm058279n.